Science Media Center GermanyApr 15, 2025
Neues #Antibiotikum könnte beim Kampf gegen #Antibiotikaresistenzen helfen: #Gepotidacin gegen Gonorrhö in Phase-3-Studie in The Lancet wirksam. Forschend betonten Relevanz neuer Wirkstoffe bei #Tripper, Pharmafirma strebt Zulassung auch in Europa an: https://www.sciencemediacenter.de/angebote/neuartiges-antibiotikum-gegen-gonorrhoe-25071/?mtm_campaign=mastodon&mtm_kwd=neuartiges-antibiotikum-gegen-gonorrhoe-25071
Matt WillemsenMar 31, 2024
Biochemists discover first new antibacterial class in decades
https://phys.org/news/2024-03-biochemists-antibacterial-class-decades.html #health #medicine #antibacterials #topoisomerases #gepotidacin
Biochemists discover first new antibacterial class in decades

Vanderbilt biochemists are part of a team taking a stride toward the development of antibacterials to treat uncomplicated urinary tract infections, a pervasive bacterial infection that affects 50%–60% of women in their lifetime.

Phys.org
AutisticMumTo3 She/herJan 30, 2023

Relief for millions of UTI sufferers with new medicine breakthrough | The Independent
#UTI
#Gepotidacin

https://www.independent.co.uk/news/health/uti-medicine-nhs-doctor-b2271717.html

Relief for millions of UTI sufferers with new medicine breakthrough

Experts are calling gepotidacin a massive step forwards in the fight against resistance to antibiotics

The Independent